CN Stock MarketDetailed Quotes

301103 Liaoning He Eye Hospital Group

Watchlist
  • 22.40
  • +0.33+1.50%
Market Closed Dec 20 15:00 CST
3.54BMarket Cap-182.11P/E (TTM)

Liaoning He Eye Hospital Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-20.12%1.38B
3.23%1.55B
-6.02%1.58B
-3.05%1.59B
-8.97%1.73B
-18.04%1.51B
-12.74%1.68B
134.57%1.64B
--1.9B
183.88%1.84B
Transactional financial assets
--59.09M
----
----
----
----
----
----
----
----
----
Notes receivable and accounts receivable
-8.45%48.81M
-0.63%58.67M
23.95%63.06M
63.34%51.42M
27.12%53.32M
49.50%59.04M
71.21%50.87M
2.35%31.48M
--41.94M
8.16%39.49M
-Accounts receivable
-8.45%48.81M
-0.63%58.67M
23.95%63.06M
63.34%51.42M
27.12%53.32M
49.50%59.04M
71.21%50.87M
2.35%31.48M
--41.94M
8.16%39.49M
Other receivables (including interest and dividends)
-11.00%6.71M
-22.56%6.94M
-24.19%7.2M
-24.64%6.62M
-8.16%7.53M
34.43%8.96M
81.18%9.49M
63.74%8.78M
--8.2M
3.09%6.67M
-Other receivable
----
-22.56%6.94M
----
----
----
34.43%8.96M
----
63.74%8.78M
----
3.09%6.67M
Advance payment
41.97%29.21M
25.61%24.2M
2.13%21.81M
71.94%25.26M
33.44%20.57M
23.57%19.27M
18.68%21.36M
-34.54%14.69M
--15.42M
-30.44%15.59M
Inventories
-10.13%85.58M
-15.58%85.9M
-9.07%85.14M
1.55%85.4M
10.33%95.23M
17.68%101.75M
9.66%93.63M
15.37%84.1M
--86.31M
12.28%86.47M
Other current assets
2.15%2.32M
-98.51%3.11M
-96.04%8.1M
-87.28%26.16M
29.74%2.28M
10,278.78%208.75M
3,244.24%204.34M
45,045.09%205.65M
--1.75M
163.34%2.01M
Total current assets
-15.48%1.62B
-8.95%1.73B
-14.34%1.76B
-10.08%1.78B
-7.07%1.91B
-4.21%1.9B
-0.49%2.06B
138.82%1.98B
143.69%2.06B
151.45%1.99B
Non Current assets
Long-term equity investment
--22.7M
----
----
----
----
----
----
----
----
----
Fixed assets
----
28.45%263.85M
----
----
----
-0.43%205.42M
----
-12.35%197.22M
----
-14.27%206.3M
Constru in process
----
441.15%33.19M
----
----
----
439.96%6.13M
----
230.03%7.78M
----
1,743.89%1.14M
Intangible assets
-6.51%33.07M
-6.32%34.31M
-8.50%34.33M
-8.95%35.04M
10.88%35.37M
15.05%36.62M
17.02%37.52M
20.10%38.49M
--31.9M
10.16%31.83M
Long deferred expense
14.96%88.31M
28.25%94.1M
25.47%95.77M
37.48%98.63M
6.49%76.81M
-4.13%73.37M
-4.90%76.33M
-9.14%71.74M
--72.13M
-12.71%76.54M
Deferred tax assets
-82.90%6.15M
-83.57%6.17M
-83.50%6.27M
-30.37%5.83M
409.05%35.99M
475.46%37.56M
518.68%38.01M
41.56%8.37M
--7.07M
28.57%6.53M
Usufruct assets
-20.06%228.72M
-14.92%245.78M
-14.51%254.95M
-10.57%264.65M
18.58%286.12M
14.41%288.87M
26.01%298.23M
21.24%295.92M
--241.28M
0.33%252.49M
Other non current assets
-60.84%6.91M
16.33%8.03M
62.90%10.29M
1,742.72%67.85M
111.33%17.65M
44.02%6.9M
99.70%6.32M
56.77%3.68M
--8.35M
-34.89%4.79M
Total non current assets
1.73%685.9M
4.67%685.43M
5.77%695.51M
12.37%700.3M
19.94%674.26M
12.99%654.87M
14.41%657.58M
5.50%623.21M
-5.51%562.19M
-6.72%579.61M
Total assets
-11.00%2.3B
-5.46%2.42B
-9.48%2.46B
-4.71%2.48B
-1.28%2.59B
-0.33%2.56B
2.75%2.72B
83.41%2.61B
82.03%2.62B
81.81%2.57B
Liabilities
Current liabilities
Notes payable and accounts payable
-9.37%74.23M
-11.40%74.13M
-18.56%74.05M
-13.07%59.23M
0.62%81.9M
21.26%83.67M
12.10%90.93M
17.90%68.13M
--81.4M
-13.79%69M
-Accounts payable
-9.37%74.23M
-11.40%74.13M
-18.56%74.05M
-13.07%59.23M
0.62%81.9M
21.26%83.67M
12.10%90.93M
17.90%68.13M
--81.4M
-13.79%69M
Contract liabilities
16.75%28.89M
43.75%27.61M
16.42%29.7M
64.43%21.43M
24.74%24.74M
2.81%19.21M
16.65%25.51M
-14.04%13.04M
--19.84M
12.62%18.68M
Salaries payable
-23.38%10.99M
24.87%9.06M
11.70%2.72M
38.27%29.42M
-7.30%14.35M
397.74%7.26M
31.08%2.43M
-9.13%21.27M
--15.48M
-1.00%1.46M
Taxs payable
-30.47%15.66M
-27.17%16.13M
-48.28%14.72M
184.91%27.41M
2.79%22.53M
28.87%22.14M
36.37%28.46M
-26.68%9.62M
--21.92M
-19.96%17.18M
Other payable (including interest and dividends)
23.08%10.41M
-16.38%9.35M
-12.16%8.85M
4.46%9.8M
-14.73%8.46M
16.43%11.18M
-66.66%10.08M
51.50%9.38M
--9.92M
25.00%9.6M
-Other payable
----
-16.38%9.35M
----
----
----
16.43%11.18M
----
51.50%9.38M
----
25.00%9.6M
Non current liabilities due within one year
-2.97%47.08M
11.91%52.11M
3.85%51.37M
12.95%50.66M
21.19%48.52M
10.40%46.56M
24.66%49.47M
0.67%44.85M
--40.04M
-24.89%42.18M
Other current liabilities
-9.34%1.46M
43.61%1.37M
32.46%1.87M
110.00%1.46M
27.03%1.61M
-19.74%957.05K
-11.01%1.41M
-24.43%696.03K
--1.26M
6.78%1.19M
Total current liabilities
-6.62%188.73M
-0.63%189.77M
-12.00%183.28M
19.42%199.41M
6.45%202.11M
19.89%190.98M
5.62%208.29M
3.62%166.99M
0.88%189.86M
-13.67%159.29M
Current liabilities
Long term account payable
----
----
----
----
----
----
----
3.57%18.56M
----
5.91%18.64M
Deferred tax liabilities
-99.46%149.5K
-99.58%121.4K
-99.46%157.42K
-82.34%172.34K
--27.68M
--28.63M
--29.38M
--975.8K
----
----
Long term deferred income
-13.13%3.09M
-18.54%2.99M
-20.27%3.15M
0.22%3.18M
-0.10%3.55M
-0.45%3.67M
-1.37%3.95M
-24.60%3.17M
--3.56M
-11.97%3.69M
Lease liabilities
-22.65%184.97M
-18.37%195.81M
-15.94%204.84M
-13.28%208.59M
20.04%239.13M
18.92%239.88M
31.38%243.67M
27.81%240.54M
--199.22M
10.32%201.71M
Total non current liabilities
-30.39%188.21M
-26.92%198.92M
-24.86%208.14M
-19.49%211.95M
22.02%270.37M
21.49%272.18M
33.46%277.01M
25.16%263.25M
11.75%221.58M
9.49%224.04M
Total liabilities
-20.22%376.94M
-16.08%388.68M
-19.34%391.43M
-4.39%411.36M
14.84%472.48M
20.82%463.16M
19.90%485.29M
15.82%430.24M
6.46%411.43M
-1.49%383.33M
Shareholders equity
Paid-in capital
0.00%158.03M
0.00%158.03M
0.00%158.03M
0.00%158.03M
0.00%158.03M
0.00%158.03M
30.00%158.03M
73.54%158.03M
--158.03M
73.54%158.03M
Capital reserve funds
0.00%1.68B
0.00%1.68B
0.00%1.68B
0.00%1.68B
0.00%1.68B
0.00%1.68B
-2.12%1.68B
187.99%1.68B
--1.68B
187.99%1.68B
Surplus reserve funds
15.04%54.15M
15.04%54.15M
15.04%54.15M
15.04%54.15M
29.96%47.07M
29.96%47.07M
29.96%47.07M
29.96%47.07M
--36.22M
47.73%36.22M
Retained profit
-52.59%108.71M
1.03%210.36M
-37.55%215.28M
-35.34%186.3M
-30.83%229.29M
-32.29%208.22M
-5.49%344.73M
-14.92%288.14M
--331.46M
-4.78%307.54M
Less:Treasury stock
--67.6M
--67.6M
--35.2M
--4.22M
----
----
----
----
----
----
Other composite income
2,052.50%73.03K
-62.66%1.85K
109.92%729.57
--787.59
--3.39K
--4.95K
--347.55
--0
----
----
Shareholders equity without minority interests
-8.56%1.93B
-2.79%2.04B
-7.06%2.07B
-4.55%2.08B
-4.14%2.12B
-4.05%2.09B
-0.41%2.23B
107.14%2.17B
--2.21B
113.53%2.18B
Minority interests
-881.02%-8.82M
-3,178.15%-6.69M
-461.91%-4.77M
-255.42%-2.97M
-138.70%-898.8K
--217.47K
--1.32M
--1.91M
--2.32M
----
Total shareholder equity
-8.94%1.93B
-3.12%2.03B
-7.33%2.07B
-4.77%2.07B
-4.28%2.11B
-4.04%2.09B
-0.35%2.23B
107.33%2.18B
109.76%2.21B
113.53%2.18B
Total liabilityies and equity
-11.00%2.3B
-5.46%2.42B
-9.48%2.46B
-4.71%2.48B
-1.28%2.59B
-0.33%2.56B
2.75%2.72B
83.41%2.61B
82.03%2.62B
81.81%2.57B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -20.12%1.38B3.23%1.55B-6.02%1.58B-3.05%1.59B-8.97%1.73B-18.04%1.51B-12.74%1.68B134.57%1.64B--1.9B183.88%1.84B
Transactional financial assets --59.09M------------------------------------
Notes receivable and accounts receivable -8.45%48.81M-0.63%58.67M23.95%63.06M63.34%51.42M27.12%53.32M49.50%59.04M71.21%50.87M2.35%31.48M--41.94M8.16%39.49M
-Accounts receivable -8.45%48.81M-0.63%58.67M23.95%63.06M63.34%51.42M27.12%53.32M49.50%59.04M71.21%50.87M2.35%31.48M--41.94M8.16%39.49M
Other receivables (including interest and dividends) -11.00%6.71M-22.56%6.94M-24.19%7.2M-24.64%6.62M-8.16%7.53M34.43%8.96M81.18%9.49M63.74%8.78M--8.2M3.09%6.67M
-Other receivable -----22.56%6.94M------------34.43%8.96M----63.74%8.78M----3.09%6.67M
Advance payment 41.97%29.21M25.61%24.2M2.13%21.81M71.94%25.26M33.44%20.57M23.57%19.27M18.68%21.36M-34.54%14.69M--15.42M-30.44%15.59M
Inventories -10.13%85.58M-15.58%85.9M-9.07%85.14M1.55%85.4M10.33%95.23M17.68%101.75M9.66%93.63M15.37%84.1M--86.31M12.28%86.47M
Other current assets 2.15%2.32M-98.51%3.11M-96.04%8.1M-87.28%26.16M29.74%2.28M10,278.78%208.75M3,244.24%204.34M45,045.09%205.65M--1.75M163.34%2.01M
Total current assets -15.48%1.62B-8.95%1.73B-14.34%1.76B-10.08%1.78B-7.07%1.91B-4.21%1.9B-0.49%2.06B138.82%1.98B143.69%2.06B151.45%1.99B
Non Current assets
Long-term equity investment --22.7M------------------------------------
Fixed assets ----28.45%263.85M-------------0.43%205.42M-----12.35%197.22M-----14.27%206.3M
Constru in process ----441.15%33.19M------------439.96%6.13M----230.03%7.78M----1,743.89%1.14M
Intangible assets -6.51%33.07M-6.32%34.31M-8.50%34.33M-8.95%35.04M10.88%35.37M15.05%36.62M17.02%37.52M20.10%38.49M--31.9M10.16%31.83M
Long deferred expense 14.96%88.31M28.25%94.1M25.47%95.77M37.48%98.63M6.49%76.81M-4.13%73.37M-4.90%76.33M-9.14%71.74M--72.13M-12.71%76.54M
Deferred tax assets -82.90%6.15M-83.57%6.17M-83.50%6.27M-30.37%5.83M409.05%35.99M475.46%37.56M518.68%38.01M41.56%8.37M--7.07M28.57%6.53M
Usufruct assets -20.06%228.72M-14.92%245.78M-14.51%254.95M-10.57%264.65M18.58%286.12M14.41%288.87M26.01%298.23M21.24%295.92M--241.28M0.33%252.49M
Other non current assets -60.84%6.91M16.33%8.03M62.90%10.29M1,742.72%67.85M111.33%17.65M44.02%6.9M99.70%6.32M56.77%3.68M--8.35M-34.89%4.79M
Total non current assets 1.73%685.9M4.67%685.43M5.77%695.51M12.37%700.3M19.94%674.26M12.99%654.87M14.41%657.58M5.50%623.21M-5.51%562.19M-6.72%579.61M
Total assets -11.00%2.3B-5.46%2.42B-9.48%2.46B-4.71%2.48B-1.28%2.59B-0.33%2.56B2.75%2.72B83.41%2.61B82.03%2.62B81.81%2.57B
Liabilities
Current liabilities
Notes payable and accounts payable -9.37%74.23M-11.40%74.13M-18.56%74.05M-13.07%59.23M0.62%81.9M21.26%83.67M12.10%90.93M17.90%68.13M--81.4M-13.79%69M
-Accounts payable -9.37%74.23M-11.40%74.13M-18.56%74.05M-13.07%59.23M0.62%81.9M21.26%83.67M12.10%90.93M17.90%68.13M--81.4M-13.79%69M
Contract liabilities 16.75%28.89M43.75%27.61M16.42%29.7M64.43%21.43M24.74%24.74M2.81%19.21M16.65%25.51M-14.04%13.04M--19.84M12.62%18.68M
Salaries payable -23.38%10.99M24.87%9.06M11.70%2.72M38.27%29.42M-7.30%14.35M397.74%7.26M31.08%2.43M-9.13%21.27M--15.48M-1.00%1.46M
Taxs payable -30.47%15.66M-27.17%16.13M-48.28%14.72M184.91%27.41M2.79%22.53M28.87%22.14M36.37%28.46M-26.68%9.62M--21.92M-19.96%17.18M
Other payable (including interest and dividends) 23.08%10.41M-16.38%9.35M-12.16%8.85M4.46%9.8M-14.73%8.46M16.43%11.18M-66.66%10.08M51.50%9.38M--9.92M25.00%9.6M
-Other payable -----16.38%9.35M------------16.43%11.18M----51.50%9.38M----25.00%9.6M
Non current liabilities due within one year -2.97%47.08M11.91%52.11M3.85%51.37M12.95%50.66M21.19%48.52M10.40%46.56M24.66%49.47M0.67%44.85M--40.04M-24.89%42.18M
Other current liabilities -9.34%1.46M43.61%1.37M32.46%1.87M110.00%1.46M27.03%1.61M-19.74%957.05K-11.01%1.41M-24.43%696.03K--1.26M6.78%1.19M
Total current liabilities -6.62%188.73M-0.63%189.77M-12.00%183.28M19.42%199.41M6.45%202.11M19.89%190.98M5.62%208.29M3.62%166.99M0.88%189.86M-13.67%159.29M
Current liabilities
Long term account payable ----------------------------3.57%18.56M----5.91%18.64M
Deferred tax liabilities -99.46%149.5K-99.58%121.4K-99.46%157.42K-82.34%172.34K--27.68M--28.63M--29.38M--975.8K--------
Long term deferred income -13.13%3.09M-18.54%2.99M-20.27%3.15M0.22%3.18M-0.10%3.55M-0.45%3.67M-1.37%3.95M-24.60%3.17M--3.56M-11.97%3.69M
Lease liabilities -22.65%184.97M-18.37%195.81M-15.94%204.84M-13.28%208.59M20.04%239.13M18.92%239.88M31.38%243.67M27.81%240.54M--199.22M10.32%201.71M
Total non current liabilities -30.39%188.21M-26.92%198.92M-24.86%208.14M-19.49%211.95M22.02%270.37M21.49%272.18M33.46%277.01M25.16%263.25M11.75%221.58M9.49%224.04M
Total liabilities -20.22%376.94M-16.08%388.68M-19.34%391.43M-4.39%411.36M14.84%472.48M20.82%463.16M19.90%485.29M15.82%430.24M6.46%411.43M-1.49%383.33M
Shareholders equity
Paid-in capital 0.00%158.03M0.00%158.03M0.00%158.03M0.00%158.03M0.00%158.03M0.00%158.03M30.00%158.03M73.54%158.03M--158.03M73.54%158.03M
Capital reserve funds 0.00%1.68B0.00%1.68B0.00%1.68B0.00%1.68B0.00%1.68B0.00%1.68B-2.12%1.68B187.99%1.68B--1.68B187.99%1.68B
Surplus reserve funds 15.04%54.15M15.04%54.15M15.04%54.15M15.04%54.15M29.96%47.07M29.96%47.07M29.96%47.07M29.96%47.07M--36.22M47.73%36.22M
Retained profit -52.59%108.71M1.03%210.36M-37.55%215.28M-35.34%186.3M-30.83%229.29M-32.29%208.22M-5.49%344.73M-14.92%288.14M--331.46M-4.78%307.54M
Less:Treasury stock --67.6M--67.6M--35.2M--4.22M------------------------
Other composite income 2,052.50%73.03K-62.66%1.85K109.92%729.57--787.59--3.39K--4.95K--347.55--0--------
Shareholders equity without minority interests -8.56%1.93B-2.79%2.04B-7.06%2.07B-4.55%2.08B-4.14%2.12B-4.05%2.09B-0.41%2.23B107.14%2.17B--2.21B113.53%2.18B
Minority interests -881.02%-8.82M-3,178.15%-6.69M-461.91%-4.77M-255.42%-2.97M-138.70%-898.8K--217.47K--1.32M--1.91M--2.32M----
Total shareholder equity -8.94%1.93B-3.12%2.03B-7.33%2.07B-4.77%2.07B-4.28%2.11B-4.04%2.09B-0.35%2.23B107.33%2.18B109.76%2.21B113.53%2.18B
Total liabilityies and equity -11.00%2.3B-5.46%2.42B-9.48%2.46B-4.71%2.48B-1.28%2.59B-0.33%2.56B2.75%2.72B83.41%2.61B82.03%2.62B81.81%2.57B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Rong Cheng Certified Public Accountants (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Smart Healthcare
Smart Healthcare
Intraday+0.66%
Gene Sequencing
Gene Sequencing
Intraday+0.58%